Generate Biomedicines, Inc 10-Q for FY2026 Q2
Generate Biomedicines, Inc. (GENB)
10-Q
2026-08-06
For: 2026-06-30
View Original
Added on
August 06, 2026
About this 10-Q
Generate Biomedicines, Inc filed this 10-Q on August 6, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.31M
- down 37.7% from $10.13M a year earlier
- Net loss
- $67.26M
- compared with a net loss of $52.43M a year earlier
- Diluted EPS
- -$0.52
- compared with -$1.94 a year earlier